Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine (azacitidine)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2013 by University of Ulm.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Dr. Richard Schlenk, University of Ulm Identifier:
First received: August 2, 2010
Last updated: August 30, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)